Pharmacokinetic Modeling of Neutralizing ADA Effects in Translational Development On-Demand Webinar Pharmacokinetic Modeling of Neutralizing ADA Effects in Translational Development CertaraMay 21, 2025
Everything you need to know about ILAP 2.0 White Paper Everything you need to know about ILAP 2.0 This white paper share’s key insights on the relaunch of MHRA’s Innovative Licensing and Access…CertaraMay 19, 2025
CERTAINTY 2025: The power of Model-Informed Drug Development Blog CERTAINTY 2025: The power of Model-Informed Drug Development We cover the key takeaways from CERTAINTY 2025, including the power of Model-Informed Drug Development…CertaraMay 16, 2025
Extrapolating AUC to Infinity BlogKnowledge Base Extrapolating AUC to Infinity AUC calculations are simple but nuanced. In this blog, we look at how to extrapolate…CertaraMay 15, 2025
Bio International Convention 2025 Conference Bio International Convention 2025 - Boston, MA - BoothCertaraMay 12, 2025
Certara’s Simcyp Educational Webinar Series: Learn from A to Z of PBBM Part 2: What is the Drug Absorption Model? On-Demand Webinar Certara’s Simcyp Educational Webinar Series: Learn from A to Z of PBBM Part 2: What is the Drug Absorption Model? Part 3 in November: Understanding the Supersaturated Dissolution in the Digestive Tract with Modeling &…CertaraMay 12, 2025
QSP Summit 2025: A New Standard in the Future of Drug Development Blog QSP Summit 2025: A New Standard in the Future of Drug Development May 5, 2025 The Quantitative Systems Pharmacology (QSP) Summit 2025, hosted by Certara, marked another…CertaraMay 5, 2025